Poor
Not Aligned
Patient Risk:
Moderate
Summary
Most safety/interaction and red-wine/resveratrol claims are unsupported by the provided label sections. Only the general statin mechanism (HMG-CoA reductase inhibition) is supported by the supplied text.
Category Scores
Accurate Statements
Lipitor (atorvastatin) is a cholesterol-lowering statin medication.
Supported generally by provided label describing LIPITOR as a synthetic lipid-lowering agent (11 DESCRIPTION) and lowering cholesterol via HMG-CoA reductase inhibition (12.1).
Lipitor lowers cholesterol by inhibiting the enzyme HMG-CoA reductase.
Explicitly stated: atorvastatin is an inhibitor of HMG-CoA reductase (11 DESCRIPTION) and 12.1 Mechanism of Action describes competitive inhibition of HMG-CoA reductase.
Unsupported Statements
Lipitor may interfere with the absorption of red wine compounds, particularly resveratrol.
No information about red wine, resveratrol, or absorption interactions appears in the provided label sections.
A study in rats reported that atorvastatin (Lipitor) reduced the bioavailability of resveratrol by 30%.
No animal-study details or resveratrol bioavailability data are provided in the supplied label sections.
A study in humans reported that atorvastatin decreased the absorption of red wine polyphenols.
No human-study details about red wine polyphenols or absorption are provided in the supplied label sections.
The mechanism of interaction between Lipitor and red wine absorption is not fully understood.
No statement about this interaction or its mechanism appears in the provided label sections.
The interaction is thought to involve inhibition of enzymes responsible for metabolism of red wine compounds.
No enzyme mechanism or red wine/resveratrol metabolism discussion is present in the provided label sections.
If Lipitor interferes with red wine absorption, red wine’s potential health benefits may be reduced.
No counseling or safety/effectiveness discussion regarding red wine benefits being reduced is included in the provided label sections.
Red wine has anti-inflammatory and antioxidant effects.
This type of general dietary-effect claim is not addressed in the provided label sections.
Contradictions
Important Omissions
Any label-supported description of contraindications, boxed warnings, dosing/administration, or specific drug-interaction information relevant to red wine/resveratrol.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Unsupported claims about drug–diet interactions (red wine/resveratrol absorption and potential reduction in benefits) could mislead patients; the provided label sections do not substantiate these statements.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Red wine/resveratrol interaction, study findings, and mechanistic speculation are not supported by the supplied prescribing information sections.
Suggested Improvement
Remove or replace red wine/resveratrol-specific interaction statements unless supported by the actual FDA label text. Retain only on-label statements such as atorvastatin’s HMG-CoA reductase mechanism and general lipid-lowering description.